UK Innovation Map
Compare placesDifferent, not ranked.
Two or three clusters, read side by side across sectors, research, companies, capital, infrastructure, government designations and UKIZ relevance. There is no score and no ranking: British clusters are different from one another, not better or worse than one another.
Choose up to three clusters
- London
- Cambridge
- Oxford
- Manchester
- Birmingham & the West Midlands
- Bristol & Bath
- Sheffield & Rotherham
- Leeds & West Yorkshire
- Liverpool City Region
- Newcastle & the North East
- Teesside & the Humber
- Edinburgh
- Glasgow & the Central Belt
- Belfast
- Cardiff & South Wales
- Southampton & Portsmouth
- Cornwall & Plymouth
- Nottingham & Derby
- Norwich & the East
Side by side
| Dimension | Liverpool City RegionNorth West | ManchesterNorth West | CambridgeEast of England |
|---|---|---|---|
| Sectors | Life Sciences, Engineering Biology, Advanced Materials Supporting: Digital Technologies, Clean Energy, Creative Industries | Advanced Materials, Life Sciences, Digital Technologies, Creative Industries Supporting: Artificial Intelligence, Advanced Manufacturing, Financial Technology, Engineering Biology | Life Sciences, Semiconductors, Engineering Biology, Artificial Intelligence Supporting: Quantum Technologies, Advanced Materials, AgriTech & FoodTech, Digital Technologies |
| Research |
|
|
|
| Companies | Not recorded on the map. | Not recorded on the map. |
|
| Infrastructure | Not recorded on the map. University research institutes, automated chemistry facilities and port and logistics assets. |
National materials and graphene facilities, teaching hospitals and clinical research capability, and a major broadcast production estate. |
University and institute laboratories, genomics and biomedical campus facilities, and semiconductor design capability. |
| Capital | A modest local investor base; public and charitable research funding dominate. | A growing regional investor base and northern funds, with growth rounds usually led from London. | Specialist deep tech and life science funds, university-linked funds, and corporate partners; strong at seed, thinner at growth stage relative to demand. |
| Government programmes |
| No place-based designation recorded. | No place-based designation recorded. |
| What exists | Infection and tropical medicine research of international standing, materials chemistry and automated discovery, a large port and a Freeport designation. | Advanced materials research including graphene and 2D materials, a large health innovation base built on hospitals and universities, a substantial digital and cyber economy, and the biggest broadcast and creative cluster outside London. | Extreme research density for its size: life sciences and genomics, semiconductor and processor IP, engineering biology and AI, with a mature spin-out culture and specialist investors who understand long timelines. |
| What's missing · UKIZ interpretation | Translation capacity: strong discovery science with limited local scale-up manufacturing and limited early-stage capital to hold companies in the city region. | The step from materials discovery to volume production, and a growth capital base proportionate to the research output. Health data at population scale is under-used by industry. | Ownership retention. Discovery and early company formation work; the Series B onward stage frequently transfers ownership overseas. Laboratory and scale-up space, power and housing also constrain growth. |
| What could connect · UKIZ interpretation | Infection and biologics research connected to North West and Teesside biomanufacturing capacity, with the port used for export rather than only import. | Materials research connected to Sheffield and Midlands manufacturing, and health innovation connected to Leeds health data capability: a corridor rather than three separate cities. | Cambridge discovery connected to UK manufacturing and biomanufacturing capacity, and to later-stage domestic capital, so that value created here is realised here rather than acquired out of the country. |
| UKIZ relevance | Discovery and manufacture here are unusually well connected, with scale-up routes that are already in use. The proposed Manchester mission treats the North West as one health and biomanufacturing geography. | Manchester has scale in four different economies that rarely commission from each other. The relevant missions concentrate on connecting health, materials, digital and creative capability. | Cambridge produces intellectual property at a rate few places match, and loses ownership of too much of it at Series B. The proposed Oxford-Cambridge zone concentrates on commercialisation and retention rather than on more discovery. |
| Last verified | 15 August 2026 | 15 August 2026 | 15 August 2026 |
Proposed by UKIZ · independent · not a government designation